期刊文献+

人重组粒细胞集落刺激因子对大鼠脑出血周围区新生血管的影响

Effect of recombinant human granulocyte colony-stimulating factor on new microvessels in rat perihematoma after intracerebral hemorrhage
下载PDF
导出
摘要 背景:研究表明人重组粒细胞集落刺激因子可动员内皮前体细胞,增加脑缺血区域新生血管生成。目的:观察人重组粒细胞集落刺激因子对大鼠脑出血周围区新生血管的影响。设计、时间及地点:随机分组设计的动物对照实验,于2006-03/11在泸州医学院中心实验室完成。材料:健康雄性SD大鼠72只,人重组粒细胞集落刺激因子。方法:72只大鼠按随机数字表法分为3组,假手术组、脑出血组、治疗组,每组24只。断尾取自体血通过鼠脑立体定向仪注入鼠脑内制备脑出血模型,假手术组用生理盐水代替自体血。治疗组于制模后1h腹腔注射人重组粒细胞集落刺激因子60μg/kg。假手术组、脑出血组不做任何处理。主要观察指标:于6,12,24,48,72h,7d6个时间点检测血肿周围区CD34+血管的表达,每个时间点检测4只。利用内皮细胞的标志性抗原CD34变化了解微血管的生成情况,CD34抗原也越多,新生血管越多。结果:脑出血组CD34+血管数明显高于假手术组(P<0.05);治疗组CD34+血管数明显高于脑出血组(P<0.05),且在72h增多明显,与7d比较差异无显著性意义(P>0.05),但与6,12,24,48h比较差异有显著性意义(P<0.05)。结论:人重组粒细胞集落刺激因子能够促进脑出血后血肿周围新生血管生成。 BACKGROUND: Recombinant human granulocyte colony-stimulating factor (rhG-CSF) can mobilize endothelial progenitor cells and enhance new vessels at cerebral ischemia region. OBJECTIVE: To investigate the effects of rhG-CSF on the new microvascular expressions in rat perihematoma after intracerebral hemorrhage. DESIGN, TIME AND SETTING: A randomized control animal experiment was performed at the Central Laboratory of Luzhou Medical College from March to November 2006. MATERIALS: A total of 72 healthy male Sprague Dawley rats and rhG-CSF were used for this study. METHODS: Seventy-two rats were equally and randomly assigned into the sham operation group, the hemorrhage group, the treatment group. According to rat brain stereotaxic atlas, models of intracerebral hemorrhage were made by infusing autoblood from rat tails. Rats in the sham operation group were infused with saline instead of autoblood. Rats in the treatment group were administered rhG-CSF (60 μ g/kg) by intraperitoneal injection at I hour after operation. Rats in the sham operation and hemorrhage groups were left intact. MAIN OUTCOME MEASURES: The microvascular expressions of CD34^+ in perihematoma were detected at 6, 12, 24, 48 and 72 hours, 7 days; Four rats in each time point. Microvascular production was measured by changes in CD34. The more the CD34 antigens, the more the new vessels were. RESULTS: In the hemorrhage group, the microvascular expressions of CD34^+ were significantly higher compared to the sham operation group (P 〈 0.05). In the treatment group, the microvascular expressions of CD34^+ were significantly higher compared to the hemorrhage group (P 〈 0.05), and the microvascular expressions of CD34^+ were significantly increased at 72 hours, and no significant difference was detected compared to at 7 days (P 〉 0.05). Significant differences were measured at 6, 12, 24 and 48 hours (P 〈 0.05). CONCLUSION: The rhG-CSF may enhance the microvascular expressions in peribematoma after hemorrhage.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第38期7539-7542,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献21

  • 1况时祥.活血化瘀药治疗脑出血急性期探要[J].中医药学刊,2004,22(8):1513-1515. 被引量:12
  • 2郭富强.实验性脑出血的缺血性损害及其防治的研究进展[J].国外医学(脑血管疾病分册),1998,6(4):231-234. 被引量:104
  • 3Asahara T, murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis.Science 1997;275(5302):964-967
  • 4Shi Q, Rafii S, Wu MH,et al. Evidence for circulating bone marrow derived endothelial cells.Blood 1998;92(2):362-367
  • 5Takahashi T, Kalka C, Masuda H, et al. Ischemia and eytokine-induced mobilization of bone barrow-derived endothelial progenitor for neovascularization.Nat Med 1999;5(4):434-438
  • 6Acarregui MJ, England KM, Richman JT, et al. Characterization of CD34 cells isolated from human fetal lung. Am J Physiol Lung Cell Mol Physiol 2003;284(2):395-401
  • 7Muller AM, Hermanns MI, Skrzynski C, et al. Expression of the endothelial markers PECAM-1 vWf and CD34 in vivo and in vitro. Exp Mol Pathol 2002;72(3):221-229
  • 8陈运贤,陆英,钟雪云,欧瑞明,管慧红,黄雪菲,韩忠朝.粒细胞集落刺激因子动员骨髓干细胞治疗大鼠缺血性脑梗死[J].中国病理生理杂志,2004,20(4):560-565. 被引量:19
  • 9Yang GY, Bets AL,Chenevert TL,et al. Experimental intracerebral hemorrhage: relationship between brain edema,blood flow,and blood-brain barrier permeability in rats.J Neurosurg 1994, 81:93-102
  • 10Shintani S, Murohara T, lkeda H, et al. Mobilization of endothelial progenitor cells in patient with acute myocardrial infarction. Circulation 2001 ;103(23):2776-2779

二级参考文献21

  • 1Veizovic T, Beech JS, Stroemer RP, et al. Resolution of stroke deficit following eontralateral grafts of conditionally immoaal neuroepithehal stem cells[J]. Stroke, 2001, 32(4):1012- 1019.
  • 2Kopen GC, Darwin JP, Donald GP. Marrow stromal cells migrate through out fore brain and cerebellum, and they differentiate in to astrocytes after injection in to neonatal mouse brains[J]. Proc Natl Acad Sci USA, 1999, 96(19) : 101 -119.
  • 3Persson L, Hardemark HG, Bolander HG, et al. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats[J]. Stroke, 1989, 20(5) :641 - 645.
  • 4Kocher AA., Schuster MD, Szabolcs ML, et al. Neovaseularization of iseliemic myoeardium by human bone - marrow -derived angioblasts prevents cardiomyocyte apoptesis reduces remodeling and improves cardiac function [ J ]. Nat Med,2001, 7(4) : 430- 436.
  • 5Scabiz WR, Kollmar R, Schwaninger M, et al. Neuroprotective effect of granulocyte colony - stimulating factor after focal cerebral ischemia[J]. Stroke,2003,34(3) : 745 - 751.
  • 6Chen J,Li Y,Wang L,et al.Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats[J].Stroke,2001,32:1005-1011.
  • 7Urbano-Ispizua A,Schmitz N,de-Witte T,et al.Allogeneic and autologous transplantation for haematological diseases,solid tummours and immune disorders:definitions and current practice in Europe[J].Bone Marrow Transplant,2002,29:639-646.
  • 8Wang Y,Tagil K,Ripa RS,et al.Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms,left ventricular perfusion and function in patients with severe chronic ischemic heart disease[J].Int J Cardiol,2005,100(3):477-483.
  • 9Li Y,Chen J,Chen XG,et al.Human marrow stromal cell therapy for stroke in rat:Neurotrophins and functional recovery[J].Neurology,2002,59:514-523.
  • 10Schneider A,Kruger C,Steigleder T,et al.The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis[J].J Clin Invest,2005,115:2083-2098.

共引文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部